The future of proteomics in toxicology is promising, with ongoing advancements in technology and computational tools. These improvements will likely lead to more comprehensive and high-throughput analyses, facilitating the discovery of novel toxicological pathways and targets. Integration of proteomic data with other omics data, such as genomics and metabolomics, will offer a systems biology perspective, enhancing our understanding of complex toxicological phenomena.
